
Home urine test could flag majority of bladder cancers, NHS trial finds
An at‑home Galeas urine test, developed by the University of Birmingham and Nonacus, detected 92% of bladder cancer cases in an NHS study of about 1,000 patients across seven hospitals; a negative result offered >99% reassurance that cancer is unlikely. While not a replacement for cystoscopies, the test could help triage patients for urgent checks and reduce invasive testing if larger trials confirm these findings. The test looks for more than 450 DNA mutations across 23 genes and is licensed to Nonacus with funding from Cancer Research UK.





